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Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder characterized by clotting in small 
blood vessels of the body (microthrombi), resulting in a low platelet count. The disease consists of the 
pentad of microangiopathic hemolytic anemia, thrombocytopenic purpura, neurologic abnormalities, fever 
and renal disease. Many symptoms could develop with acute pancreatitis but being able to differentiate 
when it is associated with any hematological conditions such as TTP is crucial to initiate a proper medical 
treatment. We present a rare case of a thirty-eight years old African American female, who presented to 
the Emergency department with an abdominal pain associated with a pancreatic condition. A vital piece in 
medical practice is recognizing lifesaving decisions in critical conditions cases.  Acute Pancreatitis (AP) is a 
well-described consequence of TTP but acute pancreatitis triggering TTP is still not as frequent.   
[N A J Med Sci. 2016;9(2):75-77.   DOI:  10.7156/najms.2016.0902075] 
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INTRODUCTION 
The annual incidence of Thrombotic thrombocytopenic 
purpura (TTP) is approximately three cases per one million 
adults per year, which makes the disease not as frequent as 
other conditions.1 At least a minimum of two diagnostic 
criteria are required to make the diagnosis, one of them being 
microangiopathic hemolytic anemia (MAHA) and 
thrombocytopenia, which may be accompanied by central 
nervous system, renal, gastrointestinal and cardiac 
involvement.2 The decisive cause of TTP is not well known, 
but one of the etiologies described by the investigators is the 
deficiency or dysfunction of A Disintegrin and 
Metalloproteinase with a Thrombospondin type 1 motif 
Member 13 (ADAMTS13) leading to accumulation of ultra-
large von Willebrand factor molecules; and subsequent von 
Willebrand factor (vWF)/platelet-rich microvascular 
thrombosis.3 Most of the time TTP in adults is idiopathic; 
however in our case TTP may be secondary.4 
  
During acute pancreatitis, pancreatic tissue damage is a result 
of intracellular activation of enzymes that lead to an 
inflammatory response and release of cytokines.5  
 
TTP as a consequence of acute pancreatitis continues to be 
rare.  
CASE REPORT 
This is a 38 yrs. old African American female who was 
admitted to the hospital with abdominal pain of 5 days after 
binge alcohol abuse.  Pain was mainly on the epigastrium 
with severe intensity, radiating to the left flank, left upper 
back and associated with nausea and vomiting.  
 
Patient’s medical history is significant for HIV since 2008 
with latest CD4 of 169/13%, alcohol abuse and two episodes 
of pancreatitis in the past. Laboratory findings during this 
admission showed an elevated amylase of 2000 U/L (N < 115 
U/L), lipase 800 U/L (N < 190 U/L). Her urea 28 mg/dl and 
creatinine 1.29 mg/dl. Total bilirubin 1.2 mg/dl, direct 
bilirubin 0.7 mg/dl, aspartate aminotransferase (AST) was 65 
IU/L, alanine aminotransferase 27 IU/L, blood glucose of 88 
ng/dl, albumin 2.9 g/dl and lactate dehydrogenase (LDH) was 
68 IU/L. Her white blood count was elevated to 8000 mcL. 
Hematocrit was 26.8 %, with hemoglobin of 8.6 g/dL and 
platelets were 10 x 103/mm3. Latest platelets count on our 
medical record system before this admission was of 292 x 
103/mm3 on September 21st, 2013 (patient did not have blood 
work done since then). Ultrasound abdomen showed no 
gallstones and enlarged pancreas, reflecting underlying 
pancreatitis. Computed tomography of abdomen also showed 
mild pancreatic inflammation with no gallbladder stone and 
small pericardial fluid. Patient was diagnosed as acute 
pancreatitis secondary to alcohol use.  
 
Patient was immediately evaluated by the medical intensive 
care unit (MICU) for severe thrombocytopenia in acute 
pancreatitis and was started on intravenous fluids as part of 
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her medical treatment. Patient received a total of 3 liters of 
normal saline divided in between bolus and continuous 
infusions with input and output well documented as per 
MICU protocol.  
 
 Second blood set showed elevated amylase of 579 U/L, 
lipase of 1362 U/L, platelets 10,000 x 103/mm3; Hct 
20.4%, Hgb 6.7 g/dl. Urea and creatinine remained stable 
but LDH rose up to 319 associated with peripheral smear 
showing significant schistocytes of 4%. Reticulocytes 
count 6.9 % with fibrinogen levels and the coagulation 
profile normal. ADAMTS 13 enzyme assay test was less 
than 10%. Based on the abnormal labs values, patient was 
diagnosed with TTP with evident MAHA and elevated 
creatinine level compared to patient baseline. All signs 
and symptoms on this patient, plus thrombocytopenia and 
mild renal impairment favor TTP rather than HUS as our 
diagnosis.  Patient had pan CT scan with negative results 
performed in order to rule out any possible malignancy as 
associated triggering factor for TTP in a patient with HIV. 
She was already on HAART therapy with a CD4 count 
more than 150 cells/mm3 and without evidence of any 
opportunistic infections. 
 
Plasmapheresis on this patient was started in addition to 
Methylprednisolone, which is a well-established TTP 
treatment.  
 
Patient received three plasmapheresis sessions as an inpatient 
with an evident improvement of platelet counts, urea and 
creatinine along with hemoglobin level. Patient’s hospital 
course took an unexpected turn when she on her 11th day of 
admission signed out against medical advice returning within 
24 hrs. of leaving. During re-admission blood work remained 
stable with Hg 10 g/dl1, HCT 30.2%, persistent low platelets 
of 31,000 x 10/mm3, WBC 15 cells/mm3, AST 45 IU/L, ALT 
45 IU/L, Alkaline Phosphatase 68 U/L and bilirubin 1.9 
mg/dl. Abdominal CT scan was not repeated this time.  As 
her medical treatment was reinstated, the recovery course 
was complicated resulting in altered mental status from her 
second session of plasma exchange post re-admission with 
normal EEG and CT head as a part of her neurological 
evaluation. Patient’s baseline mental status recovered 3 days 
post corticosteroids dose adjustment and four more session of 
plasmapheresis given. Patient was discharged on the 7th day 
of second admission with a follow up appointment scheduled 
within a month after discharge from hospital. Patient was 
stable with normal platelet count and anemia resolved. 
 
DISCUSSION  
TTP by itself is a well-known life-threatening condition and 
could be deadly if it is present during acute pancreatitis. 
MAHA and thrombocytopenia characterized TTP as a result 
of microvascular platelet clumping most of the time 
associated with ischemic organ dysfunction as neurological 
signs and renal insufficiency.  
 
In all published TTP cases, less than 12% shows a 
recognized triggering factor for this condition. Well known 
causes of secondary TTP are pregnancy, cancer, bone 
marrow transplantation and certain drugs such as 
clopidogrel.6 In this case, TTP association in between HIV 
and acute pancreatitis could trigger the question: which was 
the main starting point for TTP to develop?7 Recently, TTP 
has also been associated with Human immunodeficiency 
virus (HIV) infected patients with CD4 count less than 
100/microliters. Nevertheless, in the great majority of cases, 
TTP usually develops even without any triggering condition. 
  
Severe deficiency of ADAMTS13 has been present on most 
idiopathic cases, which prevent to process unusually large 
vWF multimers released from endothelial cells. Formations 
of microvascular thrombus may be part of the consequences. 
In adults, the main result of severe ADAMTS13 deficiency is 
often caused by ADAMTS13 auto antibodies.  Plasma 
exchange with replacement of fresh frozen plasma remains as 
treatment of choice on all patients with acute TTP. 
 
The evidence of immunological component on the course of 
the disease as auto-antibodies against ADAMTS13 in a 
relevant number of patients; provides the rationale for the use 
of corticosteroids along with plasmapheresis as part of the 
medical management.  
 
Pancreatic manifestation is common in TTP; evidence of this 
is revealed on post mortem cases by Hosler et al. in their 
study, where they found pancreatic involvement in 30 out of 
51 cases diagnosed with TTP. The mechanism for pancreatic 
injury during TTP is thought to be due to impairment of 
pancreatic circulation by thrombus occlusion of small vessels; 
resulting in ischemia.8 
 
On the other hand, as reported by Swisher et al. during the 
revision of 16 cases in which the acute inflammatory 
response present during acute pancreatitis triggered the onset 
of TTP on five of them with a median of three days. It has 
been demonstrated in in-vitro studies that inflammatory 
cytokines stimulated endothelial cell release of ultra large 
vWF multimers and inhibited the cleavage of ultra large vWF 
ADAMTS13.  
 
Prompt treatment with available effective options is 
imperative, which makes it vital to recognize this disease 
early in relation with acute pancreatitis. 
 
Our case is another example of what Swisher et al. reported 
during the series case evaluation, which revealed the short 
interval in between the first sign of acute pancreatitis and the 
subsequent TTP manifestations. 
 
CONCLUSION 
As acute pancreatitis incidence tends to increase, it is 
important to recognize its association with TTP; despite the 
presence of any other possible factors.  A high clinical 
suspicion and detailed physical examination is necessary for 
an early diagnosis an initiation of plasma exchange therapy 
remains as a lifesaving option.9,10 
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